Dr. Bellaguarda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
680 N Lake Shore Dr
Ste 1000
Chicago, IL 60611Phone+1 312-695-0838Fax+1 312-695-2310
Education & Training
University of ChicagoFellowship, Gastroenterology, 2011 - 2014
Boston University Medical CenterResidency, Internal Medicine, 2008 - 2011
Federal University of Ceara Faculty of MedicineClass of 2006
Certifications & Licensure
IL State Medical License 2011 - 2026- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) Start of enrollment: 2017 Sep 15
Roles: Principal Investigator
Publications & Presentations
PubMed
- Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease.Arthur J Kastl, Erica J Brenner, Kimberly N Weaver, Xian Zhang, Jennifer A Strople
Inflammatory Bowel Diseases. 2024-10-16 - Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis.Anne Grosen, Emanuelle Bellaguarda, Ingela Liljeqvist-Soltic, Anne-Bine Skytte, Stephen B Hanauer
Inflammatory Bowel Diseases. 2024-08-23 - 3 citationsLong-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.Erica J Brenner, Kimberly N Weaver, Xian Zhang, Arthur J Kastl, Jennifer A Strople
Clinical Gastroenterology and Hepatology. 2024-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
